Research shows that chemotherapy for inoperable non-small-cell lung cancer (NSCLC) improves survival. The economic implications of this treatment choice may be substantial. This paper reviews studies examining the cost-
Sean D. Sullivan, PhD
Advertisement
Articles by Sean D. Sullivan, PhD
Advertisement
Latest Updated Articles
- Beyond Survival: Economic Analyses of Chemotherapy in Advanced, Inoperable NSCLC
Published: February 1st 1998 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
5
